These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 26854798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin Resistance as a Novel Risk Factor for Post-ERCP Pancreatitis: A Pilot Study.
    Koksal AR, Boga S, Alkim H, Bayram M, Ergun M, Alkim C.
    Dig Dis Sci; 2016 Aug; 61(8):2397-2405. PubMed ID: 26995780
    [Abstract] [Full Text] [Related]

  • 3. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
    Chi JY, Ma LY, Zou JC, Ma YF.
    BMC Surg; 2023 Mar 23; 23(1):62. PubMed ID: 36959589
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP.
    Nakai Y, Isayama H, Sasahira N, Kogure H, Sasaki T, Yamamoto N, Saito K, Umefune G, Akiyama D, Kawahata S, Matsukawa M, Saito T, Hamada T, Takahara N, Mizuno S, Miyabayashi K, Mohri D, Hirano K, Tada M, Koike K.
    Gastrointest Endosc; 2015 Jan 23; 81(1):119-26. PubMed ID: 25442080
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W, Li Y, Zhang Q, Li X, Meng W, Zhang L, Zhang H, Zhu K, Zhu X.
    Pancreatology; 2011 Jan 23; 11(4):399-405. PubMed ID: 21894057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M, Fujita T, Sugiyama D, Masuda A, Shiomi H, Sugimoto M, Sanuki T, Hayakumo T, Azuma T, Kutsumi H.
    J Hepatobiliary Pancreat Sci; 2014 Apr 23; 21(4):275-80. PubMed ID: 24039185
    [Abstract] [Full Text] [Related]

  • 10. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.
    Ito K, Horaguchi J, Fujita N, Noda Y, Kobayashi G, Koshita S, Kanno Y, Ogawa T, Masu K, Hashimoto S.
    Dig Endosc; 2014 May 23; 26(3):442-9. PubMed ID: 23937334
    [Abstract] [Full Text] [Related]

  • 11. Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study.
    Hakuta R, Hamada T, Nakai Y, Isayama H, Kogure H, Takahara N, Mizuno S, Yagioka H, Togawa O, Matsubara S, Ito Y, Yamamoto N, Tada M, Koike K.
    J Gastroenterol Hepatol; 2019 Jun 23; 34(6):1116-1122. PubMed ID: 30152138
    [Abstract] [Full Text] [Related]

  • 12. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH, So H, Cho S, Kim N, Baik GH, Lee SK, Park DH.
    J Gastroenterol Hepatol; 2020 Jul 23; 35(7):1201-1207. PubMed ID: 31830336
    [Abstract] [Full Text] [Related]

  • 13. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC, Pradermchai K, Avula H, Sherman S, Fogel EL, Lehman GA.
    Can J Gastroenterol; 2011 Apr 23; 25(4):215-9. PubMed ID: 21523263
    [Abstract] [Full Text] [Related]

  • 14. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
    Lin Y, Liu X, Cao DQ, Tang JH, Wen JJ, Li TF, Liu PF, Xia TS.
    Eur Rev Med Pharmacol Sci; 2017 Nov 23; 21(22):5185-5190. PubMed ID: 29228432
    [Abstract] [Full Text] [Related]

  • 15. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F, Joukar F, Taherzadeh Z, Sokhanvar H, Hasandokht T.
    World J Gastroenterol; 2016 Jun 07; 22(21):5114-21. PubMed ID: 27275104
    [Abstract] [Full Text] [Related]

  • 16. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM, Abraham O, Huang R, Barth BA.
    Gastrointest Endosc; 2015 Jun 07; 81(6):1408-16. PubMed ID: 25686874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk Factors and Risk Assessment for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Zhao C, Dai T, Qian J, Ge Z.
    J Coll Physicians Surg Pak; 2024 Apr 07; 34(4):413-418. PubMed ID: 38576282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.